In the wake of the COVID-19 pandemic, Qiang Guan, Ph.D., an associate professor in 黑料社's Department of Computer Science, redirected his research to focus on drug discovery and began partnering with Cleveland Clinic to merge biology and computing for better health outcomes.
Drug discovery is the process of examining protein structures and identifying potential docking points for a molecule, such as a drug candidate, to bind with the protein.